June 24, 2020 / 10:53 AM / 13 days ago

BRIEF-iBio Says IBM Watson Health Selects Co To Receive 18 Months Of Use Of IBM Clinical Development Solution

June 24 (Reuters) - iBio Inc:

* IBIO - IBM WATSON HEALTH SELECTED IBIO TO RECEIVE 18 MONTHS OF USE OF IBM CLINICAL DEVELOPMENT SOLUTION

* IBIO INC - ANTICIPATES THAT DATA FROM PRECLINICAL IMMUNIZATION STUDIES OF TWO COVID-19 VACCINE CANDIDATES WILL BE AVAILABLE IN Q3-2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below